Navigation Links
Cellceutix Reports Confidential Disclosure Agreement Signed With Major Pharmaceutical Company
Date:3/8/2011

0;Cellceutix owns the rights to eight drug compounds, including Kevetrin, which it is developing as a treatment for certain cancers, KM-133, for the treatment of psoriasis, and KM-391, for the treatment of autism.  More information is available on the Cellceutix web site at www.cellceutix.com.

Kevetrin, KM133, and KM-391 have not been studied in humans at this time. The Company's positive results in animal studies do not necessarily guarantee success in humans, though they may form the basis for beginning Phase 1 trials.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements that reflect the Company's current expectation regarding future events. Actual events could differ materially and substantially from those projected herein and depend on a number of factors. Certain statements in this release, and other written or oral statements made by Cellceutix Corporation are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Important factors that could cause actual results to differ materially from the company's expectations include, but are not limited to, those factors that are disclosed under the heading
'/>"/>

SOURCE Cellceutix Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cellceutix Discovers Drug Activates Guardian Angel p53 in Fight Against Leukemia
2. Cellceutix Cancer Drug Kevetrin™ Shows No Genotoxicity in Study
3. Sequenom Reports Fourth Quarter and Full Year 2010 Financial Results
4. Cumberland Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
5. RBC Life Sciences Reports Sales and Earnings Growth in 2010
6. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2010 Results
7. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
8. IRIDEX Reports Strong Growth and Profits in 2010 Fourth Quarter
9. China Pharma Holdings, Inc. Reports Full Year 2010 Financial Results
10. Sequenom Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
11. Assured Pharmacy Reports Same Store Sales for the Month of December 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... , March 5, 2015 Vermillion, ... solutions company focused on gynecologic disease, announced today ... results before the market open on Wednesday, March ... and webcast at 8:30am Eastern. Conference Call & ... at 8:30am Eastern/5:30am Pacific Domestic: , 800-753-9057International: , ...
(Date:3/5/2015)... TUSTIN, Calif. , March 5, 2015  BioPhotas, ... energy products that use patented photo-therapeutic technologies to treat ... has partnered with the Semper Fi Fund to provide ... members in need of pain management solutions.  ... reported, "The first Marine who used the Celluma at ...
(Date:3/5/2015)... N.J. , March 5, 2015  Medical ... which specializes in high complexity, state-of-the-art, automated DNA-based ... new Human Papillomavirus (HPV) testing which utilizes cutting ... Each year, approximately 12,000 women are ... United States . Genital Human Papillomaviruses (HPV) ...
Breaking Medicine Technology:Vermillion to Report Fourth Quarter and Year-End 2014 Financial Results and Host an Investor Conference Call on March 25 2BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 2BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 3Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 2Medical Diagnostic Laboratories, L.L.C., the Institute for Biomarker Research Announces New HPV Tests 3
... Calif., Dec. 6, 2011 A new study ... clinics across the United States witnessed opiate prescriptions for ... 2008.  Dr. Michael Lowenstein, co-medical director for the Waismann ... , warns that this increase signals the gaining popularity ...
... a pioneer in the innovative treatment of extracorporeal ... that the first patient has been enrolled in ... of the company,s photopheresis technology in the treatment ... An estimated 15,000 new patients worldwide are diagnosed ...
Cached Medicine Technology:Rise in Opioid Use for Abdominal Pain Points to Larger Problem Warns Waismann Method Medical Director 2Rise in Opioid Use for Abdominal Pain Points to Larger Problem Warns Waismann Method Medical Director 3First Patient Enrolled in Therakos Phase Two Study for Treatment of Graft-versus-Host Disease 2First Patient Enrolled in Therakos Phase Two Study for Treatment of Graft-versus-Host Disease 3
(Date:3/6/2015)... 06, 2015 The Gluten-Free Certification ... Association, is pleased to announce that Dufflet Pastries, ... has expanded their product line of gluten-free treats ... scrumptious and as satisfying as any of their ... and never contains hydrogenated fats or oils, artificial ...
(Date:3/6/2015)... (PRWEB) March 06, 2015 FCPX developers ... from Pixel Film Studios. , “Pro3rd Hue is a lower ... Austin, CEO of Pixel Film Studios. “Blurring the line between ... , Pro3rd Hue is a set of 30 customizable lower ... X. With Pro3rd Hue, FCPX users can complement any design ...
(Date:3/6/2015)... The producers of Health Briefs TV ... Washington and vicinity. This is a city which is full ... many outdoor activities. It is also a city where healthcare ... hospitals call the city home and provide care from the ... TV program will be broadcast on CBS KLEW-TV during the ...
(Date:3/6/2015)... Fluid Running® Owner, Jennifer Conroyd, an ... Fluid Running® method 3 years ago when ... She hit upon the trifecta of combining matched-bpm music, ... maximum-resistance, deep water running technique. She not only completed ... running workout that made the experience both enjoyable and ...
(Date:3/6/2015)... March 06, 2015 As the Mayo ... be discussed, Ford & Associates Nationwide Legal Services, A.P.C., ... 2015 filed lawsuit: Verduzco v. Daiichi Sankyo, Inc., Case ... California. , “In light of a recently filed ... Benicar to evaluate and explore the Mayo Clinic's Benicar ...
Breaking Medicine News(10 mins):Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 2Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 3Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 4Health News:A New Plugin Entitled Pro3rd Hue was Released Today from Pixel Film Studios Exclusively for FCPX 2Health News:The Health Briefs TV Show to Air in Spokane, Washington 2Health News:Fluid Running®, the Revolutionary, No-Impact Running Workout, Expands Nationally with New Training Workshop 2Health News:Fluid Running®, the Revolutionary, No-Impact Running Workout, Expands Nationally with New Training Workshop 3Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 2Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 3Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 4
... biomedical sciences, they are playing a key role: living ... media populating incubators in laboratories around the world. But ... their culture dishes? Under the microscope, different cell lines ... these important research objects stop growing without apparent reason ...
... sunlight may be associated with the development of certain ... by researchers at the National Institute of Environmental Health ... "This study found that women who lived in ... developed an autoimmune muscle disease called myositis were more ...
... BEIJING, July 30 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies,Inc. ... China-based medical device,company that develops, manufactures and markets advanced ... independent internal,investigation and the expected reporting in late August ... year ended March 31, 2009 and the,quarter ended June ...
... are more apt to have joint replacement, study finds , ... protein strongly predict the risk of hip and knee joint ... shows. , The research involved 912 healthy people in Italy, ... knee or hip replacement between 1990 and 2005. Those with ...
... CAMBRIDGE, MA, July 30 /PRNewswire/ - rL Solutions, the ... today that it will be sponsoring the 2009 MITSS ... award at the MITSS 8th Annual Dinner and Fundraiser ... Copley Place Hotel. , MITSS established this award in ...
... , , SAN FRANCISCO, ... the city,s leading privately supported, non-profit animal welfare organization, has launched its ... Whether traveling out of town or staying home, out in the ... and easy reference: http://www.sfspca.org/promotions/summer-health-and-safety.html , ...
Cached Medicine News:Health News:New test for safer biomedical research results 2Health News:Sun exposure may trigger certain autoimmune diseases in women 2Health News:China Medical Technologies Announces the Substantial Completion of an Independent Internal Investigation and Expected Timing of Reporting of Unaudited Financial Results for the Quarter and Fiscal Year ended March 31, 2009 and the Quarter ended June 30, 20 2Health News:China Medical Technologies Announces the Substantial Completion of an Independent Internal Investigation and Expected Timing of Reporting of Unaudited Financial Results for the Quarter and Fiscal Year ended March 31, 2009 and the Quarter ended June 30, 20 3Health News:China Medical Technologies Announces the Substantial Completion of an Independent Internal Investigation and Expected Timing of Reporting of Unaudited Financial Results for the Quarter and Fiscal Year ended March 31, 2009 and the Quarter ended June 30, 20 4Health News:Biomarker Could Predict Severe Osteoarthritis 2Health News:rL Solutions to Sponsor 2009 MITSS HOPE Award 2Health News:The San Francisco SPCA Launches Online Guide for Summer Pet Health & Safety 2Health News:The San Francisco SPCA Launches Online Guide for Summer Pet Health & Safety 3
... The Z-View Aberrometer is the first ... needs of the dispensing Eye Care Practitioner. ... pending) the Z-View Aberrometer quickly and accurately ... well as sphere, cylinder and axis to ...
... American Industrial Laboratories, Inc. specializes in ... eyebank and laboratory specular microscopes, digital ... camera digital upgrade package. Our software ... image data correlation with rapid image ...
... user friendly computerized medical record system whose ... productivity of the practice as well as ... It provides clinical templates for commonly presenting ... also contains an exhaustive database to cover ...
... The Z-1 applanation tonometer is ... 3Z slit lamp or most "Zeiss" ... provides highly accurate intra-ocular pressure readings. ... the slit lamp and the prism ...
Medicine Products: